What is Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (688566.SS) StockRank?

MoatMap's StockRank for Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) is 65/100, with a Buy signal. This is a composite score combining Quality (75), Value (43), and Momentum (35) factor ranks across MoatMap's 19,000+ stock universe.

Does Jiangsu Jibeier Pharmaceutical Co., Ltd. have an economic moat?

Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Jiangsu Jibeier Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) is Buy, based on a StockRank of 65/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Jiangsu Jibeier Pharmaceutical Co., Ltd. in?

Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688566.SS

BUYREMOVE

Jiangsu Jibeier Pharmaceutical Co., Ltd. · Healthcare · China · $741M · Avg Vol: $4M/d

StockRank

P/E (TTM)

19.2x

ROE

10.5%

D/E

0.0x

Dividend %

2.1%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Jiangsu Jibeier is a specialized Chinese pharmaceutical company. It lacks the scale, global regulatory validation, and CDMO characteristics required to benefit from our high-conviction healthcare themes.

COMPANY DESCRIPTION

Jiangsu Jibeier Pharmaceutical Co., Ltd. is a specialty pharmaceutical company focused on the research, development, and commercialization of innovative chemical drugs and generic formulations. The company's product portfolio targets therapeutic areas such as ophthalmology, cardiovascular diseases, and oncology, with its key products holding leading positions in the domestic market. Its competitive advantage is driven by a robust R&D pipeline and a well-established clinical sales network across Chinese hospitals.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	97M	127M	133M	143M	13.8%
EPS	0.12	0.17	0.17	0.19	16.4%
Shares	187M	189M	199M	199M	+6.7%
Debt	40M	1M	3M	3M	-58.9%
Equity	250M	282M	332M	359M	12.9%
Op CF	22M	24M	32M	37M	18.1%
Inv CF	-26M	-54M	-33M	-41M	—
Fin CF	-13M	-181,904	23M	-6M	—

PRICE (1M)-13.6%

SMA 50SMA 200

$3.59

RSI (14)

41.2

52W High

$6.56

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

11.9%78.8

ROE

10.5%73.5

GP/Assets

32.8%69.7

Op. Margin

22.5%85.6

FCF/Assets

-0.8%47.8

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

0.00x98.2

Current Ratio

9.35x85.7

Value

P/E (TTM)

19.2x59.1

EV/EBITDA

15.8x25.9

P/FCF

—N/A

P/B

2.0x56.4

P/S

4.9x41.8

Div Yield

2.1%52.5

Momentum

52W High %

55%30.5

RS 6M

-24%50.3

SMA 50/200

0.91x36.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-15%28.1

FUNDAMENTALS

Market Cap

$741M

P/E (Forward)

—

Gross Margin

89.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688566.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688566.SS	Jiangsu Jibeier Pharmaceutical Co., Ltd.(you)	$741M	65	BUY
300039.SZ	Shanghai Kaibao Pharmaceutical CO.,Ltd	$822M	68	BUY
000597.SZ	Northeast Pharmaceutical Group Co., Ltd.	$983M	64	HOLD
600195.SS	China Animal Husbandry Industry Co., Ltd.	$996M	64	HOLD
600557.SS	Jiangsu Kanion Pharmaceutical Co.,Ltd.	$1.1B	65	HOLD
300705.SZ	Hunan Jiudian Pharmaceutical Co., Ltd.	$869M	70	BUY
688073.SS	Bide Pharmatech Co., Ltd.	$683M	57	HOLD
603207.SS	Shanghai Xiao Fang Pharmaceutical Co.,Ltd.	$556M	70	BUY
002550.SZ	Changzhou Qianhong Biopharma CO.,LTD	$1.2B	66	BUY
603439.SS	Guizhou Sanli Pharmaceutical Co.,Ltd	$984M	70	BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) — Stock Score Summary

Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) has a MoatMap StockRank of 65/100 based on Quality (75/100), Value (43/100), and Momentum (35/100) factor scores. The current signal is BUY. Jiangsu Jibeier is a specialized Chinese pharmaceutical company. It lacks the scale, global regulatory validation, and CDMO characteristics required to benefit from our high-conviction healthcare themes.

Key Financial Metrics

Price	$3.59
Market Cap	$741M
P/E (TTM)	19.17
Price/Book	1.96
Return on Equity	10.5%
Return on Invested Capital	11.9%
Debt/Equity	0.07
Gross Margin	89.6%
Operating Margin	22.5%
Revenue Growth	12.2%
Dividend Yield	2.1%
Free Cash Flow	$-465K

Jiangsu Jibeier Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Jiangsu Jibeier Pharmaceutical Co., Ltd.’s (688566.SS) StockRank?: MoatMap’s StockRank for Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) is 65/100, with a Buy signal. It is a composite of Quality (75), Value (43), and Momentum (35) factor ranks across MoatMap’s 19,000+ stock universe.
Does Jiangsu Jibeier Pharmaceutical Co., Ltd. have an economic moat?: Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jiangsu Jibeier Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) is Buy, based on a StockRank of 65/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jiangsu Jibeier Pharmaceutical Co., Ltd. in?: Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).